Close Menu
April 21, 2021
Sponsored by
Mission Bio

Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies

GenomeWebinar

Laurence Joseph Dineen Chair in Leukemia Research,
Chief, Molecular Cancer Medicine Service, HOPP
Memorial Sloan Kettering Cancer Center

This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies. 

Our invited speaker, Dr. Ross Levine of Memorial Sloan Kettering Cancer Center, will discuss his study published in Nature, “Single-cell mutation analysis of clonal evolution in myeloid malignancies,” which provides insights into the pathogenesis of myeloid transformation and how clonal complexity evolves with disease progression.

As part of this work, Dr. Levine’s lab performed single-cell DNA sequencing on 146 samples from 123 patients with clonal hematopoiesis, myeloproliferative neoplasms, and/or acute myeloid leukemia to delineate mutations at single clone resolution and map out the clonal complexity of each indication. Furthermore, they combined cell-surface protein expression with mutational analysis to correlate genotype and immunophenotype. 

Dr. Levine will talk about the benefits of using single-cell analysis to elucidate clonal evolution, including the ability to distinguish which mutations occur in the same clone(s), accurately measure clonal complexity, and definitively determine the order of mutations.

Dr. Ross Levine’s presentation will be followed by a live audience Q&A. 

Sponsored by

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.

Apr
16
Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

Apr
21
Sponsored by
Mission Bio

This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies. 

Apr
27
Sponsored by
Biognosys

This webinar, the first in our Next-Generation Proteomics for Precision Oncology series, will discuss how proteomics can help overcome the challenges of treating COVID-19 patients with oncologic comorbidities.

Apr
28
Sponsored by
Akoya Biosciences

Single-cell omics assays have become essential tools for identifying and characterizing cell types and states of complex tissues. While each single-modality assay reveals distinctive features about the sequenced cells, true multiomics assays are still in the early stage of development.